Home > Insider Trading > Filing (0001217234-20-000202)

Filing Details

Accession Number:: 0001217234-20-000202
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-14 19:57:09
Reporting Period:: 2020-12-14

Accepted Time:: 2020-12-14 19:57:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1217234	Caredx Inc.	CDNA	Services-Medical Laboratories (8071)	943316839

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1366412	Michael Goldberg	C/O Caredx, Inc. 1 Tower Place, 9Th Floor South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-12-14	15,620	$69.11	71,784	No	4	S	Direct
Common Stock	Disposition	2020-12-14	5,279	$70.03	66,505	No	4	S	Direct
Common Stock	Disposition	2020-12-14	2,501	$71.06	64,004	No	4	S	Direct
Common Stock	Disposition	2020-12-14	4,000	$72.02	60,004	No	4	S	Direct
Common Stock	Disposition	2020-12-14	2,600	$73.36	57,404	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $68.63 to $69.62, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $69.64 to $70.61, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $70.66 to $71.64, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $71.71 to $72.36, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $73.03 to $73.77, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.